We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+1.78%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+377.38%
AUM
$3.85B
AUM Growth
-$284M
Cap. Flow
-$132M
Cap. Flow %
-3.43%
Top 10 Hldgs %
21.54%
Holding
5,768
New
656
Increased
2,740
Reduced
1,651
Closed
687

Sector Composition

Rank Sector Weight
1 Technology 21.48%
2 Financials 7.64%
3 Healthcare 7.18%
4 Consumer Discretionary 6.43%
5 Industrials 6.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QTOP
1926
iShares Nasdaq Top 30 Stocks ETF
QTOP
$268M
$138K ﹤0.01%
4,601
-7,946
-63% -$250K
MNKD icon
1927
MannKind Corp
MNKD
$1.19B
$138K ﹤0.01%
56,139
+34,460
+159% +$154K
CRVS icon
1928
Corvus Pharmaceuticals
CRVS
$1.1B
$137K ﹤0.01%
9,362
+8,731
+1,384% +$139K
VOO icon
1929
Vanguard S&P 500 ETF
VOO
$956B
$137K ﹤0.01%
229
-2,417
-91% -$1.51M
APTV icon
1930
Aptiv
APTV
$12.3B
$137K ﹤0.01%
1,968
-2,809
-59% -$216K
ZBRA icon
1931
Zebra Technologies
ZBRA
$13.5B
$137K ﹤0.01%
653
-511
-44% -$120K
ELVN icon
1932
Enliven Therapeutics
ELVN
$3.78B
$136K ﹤0.01%
3,471
+1,167
+51% +$32.3K
ICHR icon
1933
Ichor Holdings
ICHR
$2.17B
$136K ﹤0.01%
2,918
+2,175
+293% +$84.6K
ARR
1934
Armour Residential REIT
ARR
$2.32B
$136K ﹤0.01%
8,151
+6,122
+302% +$108K
MRP
1935
Millrose Properties Inc
MRP
$4.66B
$136K ﹤0.01%
4,855
-7,260
-60% -$219K
BEAM icon
1936
Beam Therapeutics
BEAM
$2.68B
$136K ﹤0.01%
5,702
+3,718
+187% +$103K
SEM
1937
DELISTED
Select Medical
SEM
$136K ﹤0.01%
8,336
+2,013
+32% +$31.5K
FHB icon
1938
First Hawaiian
FHB
$3.41B
$136K ﹤0.01%
5,500
+2,232
+68% +$57.5K
URE icon
1939
ProShares Ultra Real Estate
URE
$60.1M
$136K ﹤0.01%
+2,273
New +$143K
CALY
1940
Callaway Golf Company
CALY
$3.28B
$135K ﹤0.01%
9,755
+225
+2% +$3.16K
EVTC icon
1941
Evertec
EVTC
$1.97B
$135K ﹤0.01%
4,779
-836
-15% -$23.7K
EE icon
1942
Excelerate Energy
EE
$1.19B
$135K ﹤0.01%
4,033
+3,217
+394% +$115K
MBIN icon
1943
Merchants Bancorp
MBIN
$2.49B
$135K ﹤0.01%
3,139
+425
+16% +$17.3K
ALK icon
1944
Alaska Air
ALK
$5.11B
$135K ﹤0.01%
3,662
-2,667
-42% -$129K
SGHC icon
1945
SGHC Ltd
SGHC
$7.57B
$134K ﹤0.01%
12,433
+9,915
+394% +$101K
PVLA
1946
Palvella Therapeutics
PVLA
$2.05B
$134K ﹤0.01%
1,076
+639
+146% +$66.7K
MD icon
1947
Pediatrix Medical
MD
$2.2B
$134K ﹤0.01%
6,263
+1,848
+42% +$38.5K
KBH icon
1948
KB Home
KBH
$3.5B
$134K ﹤0.01%
2,588
-304
-11% -$17.9K
IPAR icon
1949
Interparfums
IPAR
$4.07B
$134K ﹤0.01%
1,473
-1,399
-49% -$133K
REM icon
1950
iShares Mortgage Real Estate ETF
REM
$549M
$134K ﹤0.01%
6,229
-8,193
-57% -$184K

Similar funds

Tower Research Capital (TRC)'s Q1 2026 Portfolio in Review

As of Q1 2026, Tower Research Capital (TRC) held 5,768 positions worth $3.85B, down 6.9% from $4.13B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Tower Research Capital (TRC) withdrew a net $132M in Q1 2026, closing 687 positions and reducing 1,651 holdings. Its most notable exit was State Street SPDR Bloomberg Short Term High Yield Bond ETF, an estimated $58.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 30% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Core US Aggregate Bond ETF worth $39.7M.

  • Tower Research Capital (TRC)'s largest Q1 2026 buy was iShares Core US Aggregate Bond ETF: 400,371 shares worth $39.7M.
  • Tower Research Capital (TRC) added most to Invesco QQQ Trust in Q1 2026, an estimated $147M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2026 reduction was NVIDIA, cutting an estimated $104M.
  • Tower Research Capital (TRC) fully exited State Street SPDR Bloomberg Short Term High Yield Bond ETF in Q1 2026, selling an estimated $58.1M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 22% of its $3.85B portfolio in Q1 2026.
  • Tower Research Capital (TRC) opened 656 new positions and closed 687 in Q1 2026.
  • Tower Research Capital (TRC)'s portfolio value fell 6.9% quarter-over-quarter to $3.85B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.